Incidence of symptomatic and asymptomatic dengue virus infections in Maracay, Venezuela: 2006 - 2007;Incidencia de infecciones sintomáticas y asintomáticas por virus dengue en Maracay, Venezuela: 2006 - 2007

Boletin de Malariologia y Salud Ambiental

Volumn 50, Issue 1, 2010, Pages 65-74

  Espino, Carlos ^a   Comach, Guillermo ^a   Sierra, Gloria ^a   Guzmán, Diamelis ^a   Camacho, Daría Elena ^a   De Quintana, Maritza Cabello ^a,b   Chiarello, Anna ^a,b   Kochel, Tadeusz ^c  

^a UNIVERSIDAD DE CARABOBO   (Venezuela)

^b Corporación de Salud Del Estado Aragua ^*  (Venezuela)

^c Peru   (Peru)

Author keywords

active surveillance; Dengue; IgM; incidence

Indexed keywords

EID: 80051917157     PISSN: 16904648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Balmaseda A., Hammond S., Tellez Y., Imhoff L., Rodríguez Y., Saborío S. et al. (2006). High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop. Med. Int. Health. 11: 935-942. (Pubitemid 43846454)
2. Barrera R., Delgado N., Jiménez M. & Villalobos I. (2000). Estratifcación de una ciudad hiperendémica en dengue hemorrágico. Pan. Am. J. Public Health. 8: 225-233.
3. Barrera R., Delgado N., Jiménez M. & Valero S. (2002). Eco-epidemiological factors associated with hyperendemic dengue haemorrhagic fever in Maracay city, Venezuela. Pan. Am. J. Public Health. 26: 84-95. (Pubitemid 37168487)
4. Camacho D. E., Ferrer E., Rodríguez-Henríquez F., Sierra G., Bosch I., Schmidt D. et al. (2009). Genotipifcación de virus dengue tipo 1 circulantes en el estado Aragua durante el período 1997 -2007. Salus. 12 (Supl 1): 73-87.
5. Chadee D. D., Willimas F. L. R. & Kitron U. D. (2005). Impact of vector control on a dengue fever outbreak in Trinidad, West Indies, in 1998. Trop. Med. Int. Health. 10: 748-754. (Pubitemid 41098142)
6. Dean A. G., Dean J. A., Coulombier D., Brendel K. A., Smith D. C., Burton A. H. et al. (1996). Epi Info: a word processing, database, and statistics program for public health on IBM compatible microcomputers. 6. Atlanta: Centers for Disease Control and Prevention. Documento en línea: http://www.cdc.gov/EpiInfo/downloads.htm (Consultado: 2009, Septiembre 07).
7. Endy T., Chunsuttiwat S., Nisalak A., Libraty D., Green S., Rothman A. et al. (2002). Epidemiology of inapparent and symptomatic acute dengue virus infection: A prospective study of primary school children in Kamphaeng Phet, Thailand. Am. J. Epidemiol. 156: 40-51. (Pubitemid 34680622)
8. Endy T. P., Nisalak A., Chunsuttiwat S., Libraty D. H., Green S., Rothman A. L. et al. (2002). Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am. J. Epidemiol. 156: 52-59. (Pubitemid 34680623)
9. Feldman K. (2004). Endemic dengue: surveillance strategy challenges. Rev. Soc. Bras. Med. Trop. 37: 413-415.
10. a Edición, Maracay, Venezuela.
11. Gubler D. J. & Clark G. G. (1995) Dengue/Dengue Hemorrhagic Fever: The emergence of a global health problem. Emerg. Infect. Dis. 1: 55-57.
12. Gubler D. (2002). How effectively is epidemiological surveillance used for dengue programme planning and epidemic response? Dengue Bull. 26: 96-106. (Pubitemid 37168488)
13. Guzmán M. G., Kourí G. & Bravo J. R. (1999) La Emergencia de la febre hemorrágica en las Américas. Reemergencia del dengue. Rev. Cubana Med. Trop. 51: 5-13.
14. Halstead S. (2000) Successes and failures in dengue control - Global Experience. Dengue Bull. 24: 60-70.
15. Hayes C., Phillips I., Callahan J., Griebenow W., Hyams K., Wu S. et al. (1996). The epidemiology of dengue virus infection among urban, jungle, and rural populations in the Amazon region of Peru. Am. J. Trop. Med. Hyg. 55: 459-463. (Pubitemid 26398315)
16. Koraka P., Zeller H., Niedrig M., Osterhaus A. & Groen J. (2002). Reactivity of serum samples from patients with a favivirus infection measured by immunofuorescence assay and ELISA. Microbes Infect. 4: 1209-1215. (Pubitemid 35435274)
17. Kuno G., Gómez I. & Gubler D. J. (1987). Detecting artifcial anti-dengue IgM immune complexes using an enzyme-linked immunosorbent assay. Am. J. Trop. Med. Hyg. 36: 153-159. (Pubitemid 17033991)
18. Kuno G. (1997). Factor infuencing the transmission of dengue viruses. pp. 61-80 En: Dengue and dengue hemorrhagic fever. Eds. Gubler DJ & Kuno G. Wallingford UK: CAB International.
19. Lanciotti R. S., Calisher C. H., Gubler D. J., Chang G J. & Vorndam A. V. (1992). Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction J. Clin. Microbiol. 30: 545-551.
20. Nagao Y., Thavara U., Chitnumsup P., Apiwat-Tawatsin A., Chansang C. & Campbell-Lendrum D. (2003). Climatic and social risk factors for Aedes infestation in rural Thailand. Trop. Med. Int. Health. 8: 650-659 (Pubitemid 36836511)
21. PAHO (1990). Dengue hemorrhagic fever in Venezuela. Epidemiol. Bull. 11: 7-9.
22. PAHO (1997). Dengue and Dengue Hemorrhagic Fever in the Americas: guidelines for prevention and control. Scientifc publication N° 548. Washington, USA.
23. Phuong H., de Vries P., Nga T., Giao P., Hung le Q., Binh T. et al.(2006).Dengue as a cause of acute undifferentiated fever in Vietnam. BMC Infect. Dis. 6: 123.
24. Porter K. R., Beckett C. G., Kosasih H., Tan R., Alisjahbana B., Rudiman P. I. et al. (2005). Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia. Am. J. Trop. Med. Hyg. 72: 60-66. (Pubitemid 41270309)
25. Querales J. (2002). Dengue: causas, características clínicas y prevención Caracas. 110: 328-332
26. Thai K., Binh T., Giao P., Phuong H., Hung le Q., Van Nam N. et al.(2005). Seroprevalence of dengue antibodies, annual incidence and risk factors among children in southern Vietnam. Trop. Med. Int. Health. 10: 379-386. (Pubitemid 40569257)
27. Vázquez S., Valdés O., Pupo M., Delgado I., Alvarez M., Pelegrino J. et al. (2003). MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination. J. Virol. Meth. 10: 179-184. (Pubitemid 36645262)
28. Vaughn D. W., Green S., Kalayanarooj S., Innis B. L., Nimmannitya S., Suntayakorn S. et al. (2000). Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181: 2-9. (Pubitemid 30049026)
29. Vorndam V & Kuno G. (1997). Laboratory diagnosis of dengue virus infections. pp. 313-334. En: Dengue and dengue hemorrhagic fever. Eds. Gubler DJ & Kuno, G. CAB International Wallingford, UK
30. WHO (1997a). Dengue Hemorrhagic Fever: diagnosis, treatment, prevention and control. World Health Organization, Geneva, Switzerland.
31. WHO (1997b). Technical Meeting. Management of Dengue Epidemic. Documento en línea: http:// www.searo.who.int/en/Section10/Section332/ Section519.htm. (Consultado: 2009, Septiembre 07).
32. WHO (2006). Meeting of the WHO Task Force on Clinical Trials of Dengue Vaccines. Documento en línea: www.who.int/vaccines-documents/ (Consultado: 2009, Septiembre 07).
33. WHO (2008).Guidelines for the Clinical Evaluation of Dengue Vaccines in Endemic Areas. World Health Organization . Documento en línea: www. who.int/vaccines-documents/. (Consultado: 2009, Septiembre 07).
34. WHO (2002). DengueNet. World Health Organization. Documento en línea: http://www. who.int/csr/disease/dengue/denguenet/en/index. html/. (Consultado: 2009, Septiembre 07).